Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease

2009 ◽  
Vol 24 (6) ◽  
pp. 899-905 ◽  
Author(s):  
Gabriella Santangelo ◽  
Carmine Vitale ◽  
Luigi Trojano ◽  
Francesca Verde ◽  
Dario Grossi ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Pathological Gambling ◽  
Cognitive Dysfunctions

scholarly journals Pathological gambling in Parkinson's disease

BMJ ◽  
2007 ◽  
Vol 334 (7598) ◽  
pp. 810-811 ◽  
Author(s):  
Sui H Wong ◽  
Malcolm J Steiger
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Pathological Gambling

Is pathological gambling in Parkinson's disease reduced by amantadine?

2011 ◽  
Vol 69 (1) ◽  
pp. 213-214 ◽  
Author(s):  
Jee-Young Lee ◽  
Han- Joon Kim ◽  
Beom S. Jeon
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Pathological Gambling

Pathological gambling in patients with Parkinson's disease is associated with fronto-striatal disconnection: A path modeling analysis

2011 ◽  
Vol 26 (2) ◽  
pp. 225-233 ◽  
Author(s):  
Roberto Cilia ◽  
Sang Soo Cho ◽  
Thilo van Eimeren ◽  
Giorgio Marotta ◽  
Chiara Siri ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Pathological Gambling ◽  
Path Modeling ◽  
Modeling Analysis

Plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with cognitive dysfunctions

2005 ◽  
Vol 43 (10) ◽  
Author(s):  
Stefano Zoccolella ◽  
Paolo Lamberti ◽  
Giovanni Iliceto ◽  
Cosimo Diroma ◽  
Elio Armenise ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Plasma Homocysteine ◽  
Vitamin B ◽  
Elevated Plasma ◽  
Cognitive Dysfunctions ◽  
The Relationship ◽  
Late Stages

AbstractElevated plasma homocysteine (Hcy) concentrations are associated with Alzheimer's disease and vascular dementia. Several recent reports have indicated that L-dopa treatment is an acquired cause of hyperhomo-cysteinemia. Despite the fact that a large proportion of Parkinson's disease (PD) patients develop cognitive dysfunctions or dementia, particularly in the late stages of the illness and after long-term L-dopa treatment, the relationship between Hcy and dementia in PD has not been fully investigated. The aim of this study was to evaluate plasma Hcy levels in a group of L-dopa-treated PD patients with cognitive impairment and to elucidate a possible role of Hcy in the development of cognitive dysfunctions in PD. We compared Hcy, vitamin B

Electrophysiological correlates of visual categorization: evidence for cognitive dysfunctions in early Parkinson’s disease

2002 ◽  
Vol 13 (2) ◽  
pp. 153-158 ◽  
Author(s):  
Andrea Antal ◽  
Szabolcs Kéri ◽  
György Dibó ◽  
György Benedek ◽  
Zoltán Janka ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Cognitive Dysfunctions ◽  
Visual Categorization ◽  
Early Parkinson’S Disease
Sign in / Sign up

Export Citation Format

Share Document